NovaBay Pharmaceuticals (United States)
- Research works
- 50 ▼ 65% vs 2013–17
- Citations
- 1.3k 26.1 per fractional work
- Top-10% rate
- 44.5% record average 16.5%
- Open access
- 37% world 28%
Not ranked overall: NovaBay Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 25.4×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 25.4×
- Chemistry 11.7×
- Chemical Engineering 10.3×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Medicine 2.1×
- Agricultural and Biological Sciences 1.7×
- Environmental Science 0.5×
- Economics, Econometrics and Finance 0.3×
- Business, Management and Accounting 0.2×
- Social Sciences 0.1×
Which keywords describe research at NovaBay Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Synthesis, Antibiotic Resistance, Medicinal Chemistry, Antimicrobial, Immune Response, Anticancer and Antioxidant Activity.
- Infectious Diseases
- Wound Healing
- Genetic Analysis
- Colloidal Particles
- Staphylococcus aureus
- Heterocyclic Compounds
- Healthcare-Associated Infections
- Surfactants
- Diagnosis
- Antimicrobial Polymers
- Polymerization
- Non-antibiotic Drugs
- Antibacterial Agents
- Quaternary Ammonium Compounds
- Virulence Factors
- Antioxidant Activity
- Immune Response
- Nanoparticles
- Antibiotic Resistance
- Synthesis
- Epidemiology
- Inflammation
- Medicinal Chemistry
- Antimicrobial
- Anticancer
- Antimicrobial Resistance
- Biological Activities
- Treatment
- Gene Therapy
- Phenothiazines
- Vaccine
- Biocidal Surfaces
- Glycosylation
- Anticancer Agents
- Immunity
- Pathogenesis
- Clinical Management
- Emulsions
- MRSA
- Drug Discovery
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology8▲ 4.0×29 topics
- Synthesis4▲ 12×6 topics
- Inflammation3▲ 2.7×15 topics
- Antibiotic Resistance3▲ 15×7 topics
- Medicinal Chemistry3▲ 15×7 topics
- Nanoparticles3▲ 3.9×5 topics
- Antimicrobial2▲ 17×3 topics
- Immune Response2▲ 7.4×10 topics
- Anticancer2▲ 22×2 topics
- Antioxidant Activity2▲ 7.9×3 topics
- Antimicrobial Resistance2▲ 17×4 topics
- Virulence Factors2▲ 22×4 topics
- Biological Activities2▲ 21×2 topics
- Quaternary Ammonium Compounds2▲ 164×2 topics
- Treatment2▲ 3.0×8 topics
- Antibacterial Agents2▲ 48×3 topics
- Gene Therapy2▲ 14×3 topics
- Non-antibiotic Drugs2▲ 211×1 topic
- Phenothiazines2▲ 211×1 topic
- Polymerization2▲ 20×3 topics
- Vaccine2▲ 8.8×7 topics
- Antimicrobial Polymers2▲ 256×1 topic
- Biocidal Surfaces2▲ 256×1 topic
- Diagnosis2▲ 3.4×8 topics
- Glycosylation2▲ 15×3 topics
- Surfactants2▲ 27×2 topics
- Anticancer Agents2▲ 13×4 topics
- Healthcare-Associated Infections2▲ 26×2 topics
- Immunity2▲ 9.6×4 topics
- Heterocyclic Compounds1▲ 18×2 topics
- Pathogenesis1▲ 4.8×8 topics
- Staphylococcus aureus1▲ 36×2 topics
- Clinical Management1▲ 13×2 topics
- Colloidal Particles1▲ 44×1 topic
- Emulsions1▲ 47×1 topic
- Genetic Analysis1▲ 52×1 topic
- MRSA1▲ 73×1 topic
- Wound Healing1▲ 12×4 topics
- Drug Discovery1▲ 6.2×5 topics
- Infectious Diseases1▲ 9.1×3 topics
Which research topics does NovaBay Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Fluorine in Organic Chemistry and Organic Chemistry Cycloaddition Reactions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 2 Animal Virus Infections Studies Animal Science and Zoology 0 works
- 3 Fluorine in Organic Chemistry Pharmaceutical Science 0 works
- 4 Organic Chemistry Cycloaddition Reactions Organic Chemistry 0 works
- 5 Chemical Synthesis and Reactions Organic Chemistry 0 works
- 6 Virus-based gene therapy research Genetics 0 works
- 7 Protein Degradation and Inhibitors Molecular Biology 0 works
- 8 Folate and B Vitamins Research Rheumatology 0 works
- 9 Respiratory viral infections research Epidemiology 0 works
- 10 Peptidase Inhibition and Analysis Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has NovaBay Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 65% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Emeryville
- Alcohol Research Group
- Joint BioEnergy Institute
- Ernest Gallo Clinic and Research Center
- Sound Agriculture (United States)
- Adamas Pharmaceuticals (United States)
- KineMed (United States)
- Santen (United States)
- CEP America
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.